{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:21:30Z","timestamp":1777890090635,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004320","name":"Philips","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jvs.2020.08.146","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T04:06:11Z","timestamp":1602043571000},"page":"911-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Outcomes of treatment with paclitaxel-coated devices for peripheral arterial disease"],"prefix":"10.1016","volume":"73","author":[{"given":"Tanner I.","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gathe","family":"Kiwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Mohamedali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Mena-Hurtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Mojibian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul J.","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassius Iyad","family":"Ochoa Chaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.jvs.2020.08.146_bib1","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"issue":"Suppl","key":"10.1016\/j.jvs.2020.08.146_bib2","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.08.146_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jvs.2019.05.034","article-title":"Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries","volume":"71","author":"Mohapatra","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.08.146_bib4","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.08.146_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.08.146_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Interv"},{"key":"10.1016\/j.jvs.2020.08.146_bib7","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2020.08.146_bib9","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","article-title":"Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon","volume":"73","author":"Schneider","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.08.146_bib10","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.jcin.2019.08.025","article-title":"Safety of paclitaxel-coated balloon angioplasty for femoropopliteal peripheral artery disease","volume":"12","author":"Ouriel","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.08.146_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.08.146_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00270-019-02324-4","article-title":"Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices","volume":"43","author":"Dake","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2020.08.146_bib13","doi-asserted-by":"crossref","first-page":"e008528","DOI":"10.1161\/CIRCINTERVENTIONS.119.008528","article-title":"Mortality after paclitaxel coated balloon angioplasty and stenting of superficial femoral and popliteal artery in the Vascular Quality Initiative","volume":"13","author":"Bertges","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.08.146_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ahj.2019.07.014","article-title":"Use and 1-year outcomes with conventional and drug-coated balloon angioplasty in patients with lower extremity peripheral artery disease","volume":"217","author":"Long","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2020.08.146_bib15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of survival with femoropopliteal artery revascularization with drug-coated devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvs.2020.08.146_bib16","first-page":"ehz698","article-title":"Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis","author":"Freisinger","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2020.08.146_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ejvs.2019.12.034","article-title":"Editor\u2019s choice\u2014long term survival after femoropopliteal artery revascularisation with paclitaxel coated devices: a propensity score matched cohort analysis","volume":"59","author":"Behrendt","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2020.08.146_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jvs.2019.10.010","article-title":"Rigorous focus on paclitaxel-related mortality in femoropopliteal artery disease","volume":"71","author":"Ducasse","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.08.146_bib19","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jvs.2019.10.100","article-title":"Paclitaxel-coated peripheral artery devices are not associated with increased mortality","volume":"72","author":"Kumins","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.08.146_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1526602820904783","article-title":"Mortality after paclitaxel-coated device use in patients with chronic limb-threatening ischemia: a systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Dinh","year":"2020","journal-title":"J\u00a0Endovasc Ther"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521420321339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521420321339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:31:44Z","timestamp":1760041904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521420321339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0741521420321339"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2020.08.146","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of treatment with paclitaxel-coated devices for peripheral arterial disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2020.08.146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}